Radcliffe Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-412,096
| Closed | -$4.22M | – | 680 |
|
|
2023
Q1 | $4.22M | Hold |
412,096
| – | – | 0.26% | 119 |
|
|
2022
Q4 | $4.14M | Buy |
412,096
+591
| +0.1% | +$5.94K | 0.13% | 242 |
|
|
2022
Q3 | $4.06M | Buy |
411,505
+30
| +0% | +$296 | 0.1% | 351 |
|
|
2022
Q2 | $4.01M | Buy |
411,475
+12,103
| +3% | +$118K | 0.09% | 365 |
|
|
2022
Q1 | $3.89M | Hold |
399,372
| – | – | 0.09% | 365 |
|
|
2021
Q4 | $3.9M | Sell |
399,372
-628
| -0.2% | -$6.13K | 0.1% | 298 |
|
|
2021
Q3 | $3.91M | Buy |
+400,000
| New | +$3.91M | 0.11% | 251 |
|